Unknown

Dataset Information

0

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19.


ABSTRACT: SARS-CoV-2, a rapidly spreading new strain of human coronavirus, has affected almost all the countries around the world. The lack of specific drugs against SARS-CoV-2 is a significant hurdle towards the successful treatment of COVID-19. Thus, there is an urgent need to boost up research for the development of effective therapeutics against COVID-19. In the current study, we investigated the efficacy of 81 medicinal plant-based bioactive compounds against SARS-CoV-2 Mpro by using various in silico techniques. The interaction affinities of polyphenolic compounds towards SARS-CoV-2 Mpro was assessed via intramolecular (by Quantum Mechanic), intermolecular (by Molecular Docking), and spatial (by Molecular Dynamic) simulations. Our obtained result demonstrate that Hesperidin, rutin, diosmin, and apiin are most effective compounds agents against SARS-CoV-2 Mpro as compared to Nelfinavir (positive control). This study will hopefully pave a way for advanced experimental research to evaluate the in vitro and in vivo efficacy of these compounds for the treatment of COVID-19.

SUBMITTER: Adem S 

PROVIDER: S-EPMC8957318 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitors to unveil a hope against COVID-19.

Adem Şevki Ş   Eyupoglu Volkan V   Ibrahim Ibrahim M IM   Sarfraz Iqra I   Rasul Azhar A   Ali Muhammad M   Elfiky Abdo A AA  

Computers in biology and medicine 20220326


SARS-CoV-2, a rapidly spreading new strain of human coronavirus, has affected almost all the countries around the world. The lack of specific drugs against SARS-CoV-2 is a significant hurdle towards the successful treatment of COVID-19. Thus, there is an urgent need to boost up research for the development of effective therapeutics against COVID-19. In the current study, we investigated the efficacy of 81 medicinal plant-based bioactive compounds against SARS-CoV-2 M<sup>pro</sup> by using vario  ...[more]

Similar Datasets

| S-EPMC8592230 | biostudies-literature
| S-EPMC7678360 | biostudies-literature
| S-EPMC7649659 | biostudies-literature
| S-EPMC10385622 | biostudies-literature
| S-EPMC10091420 | biostudies-literature
| S-EPMC8038614 | biostudies-literature
| S-EPMC8918422 | biostudies-literature
| S-EPMC7786323 | biostudies-literature
| S-EPMC8214915 | biostudies-literature
| S-EPMC7441807 | biostudies-literature